Log in or Sign up for Free to view tailored content for your specialty!
Pharmacology News
Doxy-PEP, diabetic foot infections and more: The year in ID guidelines
New guidance was published in 2023 for STD prevention, diabetic foot infections, infective endocarditis and more.
Paxlovid unlikely to contribute to COVID-19 rebound
SARS-CoV-2 rebound risk is more likely related to the individual person, rather than reinfection or resistance to treatment such as Paxlovid, according to two studies.
Log in or Sign up for Free to view tailored content for your specialty!
Targeting obesity may be ‘highly effective strategy’ for treating HFpEF, ASCVD
Findings from two cardiovascular outcome trials revealed that targeting obesity could become a major focus for treating cardiovascular disease and heart failure with preserved ejection fraction in the future, according to a speaker.
#OICAwarenessDay campaign looks to break silence, stigma of ‘underdiagnosed population’
Salix Pharmaceuticals has joined forces with the U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders to declare December 5 as Opioid-Induced Constipation Awareness Day, according to a company press release.
Routine lab monitoring for cefazolin, ceftriaxone in OPAT may be ‘excessive’
Few adverse events following outpatient parenteral antimicrobial therapy containing cefazolin and ceftriaxone were identified using routine laboratory monitoring, leading researchers to say the practice may be “excessive.”
Weight-loss program in HF clinic setting may benefit patients with obesity, HF
A cardiology-driven clinic for outpatients with heart failure appears to be an effective setting for weight loss in patients with obesity and HF, according to a research letter published in JACC: Advances.
Prosthetic joint infection therapy gets breakthrough designation from FDA
The FDA designated a drug-device combination for periprosthetic joint infection in hip and knee replacement patients as a breakthrough therapy, which may accelerate its approval, the manufacturer said.
No difference in most long-term morbidity, mortality outcomes for three BP medications
In adults with hypertension and at least one CHD risk factor followed for up to 23 years, three antihypertensive medications did not differ in CVD mortality, according to long-term results of the ALLHAT trial.
Black, Hispanic, Latino patients with ASCVD less likely to get optimal care
Despite population-wide improvements in use of lipid-lowering medication and cholesterol control since 1999, significant racial and ethnic disparities persist among patients with a history of atherosclerotic CVD, researchers reported.
Antibiotic stewardship bundle reduces prescribing without increasing health care contacts
An outpatient antibiotic stewardship bundle initiative reduced unnecessary antibiotic prescribing for respiratory infections without increasing repeat health care contacts, a recent study showed.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read